Grow New Brain Cells

By Forrest Ritiker

For years, scientists believed brain shrinkage was inevitable and irreversible.

Cutting-edge research has shown that brain cells can regenerate.

An amino acid called taurine plays an important role in creating new brain cells.

Researchers found that taurine increased the growth of brain cells by activating “sleeping” stem cells. Taurine also increased the survival of new neurons, resulting in an increase in adult brain cell creation.1-3

Recent studies reveal that taurine has unique biochemical properties that promote new brain cell formation.4,5 Animal studies show that taurine triggers new brain cells to grow in the hippocampus, the area of the brain most concerned with memory.1,6 This can lead to dramatic improvements in cognition and recall.7,8 Low levels of taurine have been observed in patients with Parkinson’s disease.9,10

In addition to these impressive brain benefits, taurine also boosts cardiac function and reduces arterial stiffness as well as reducing the negative impacts of metabolic syndrome.11-16 In fact, taurine supplementation added to the drug metformin has been shown to offer tremendous reductions in tissue damage.17

Taurine levels fall significantly with age, leaving the brain, heart, kidneys, and other tissues deprived of this vital healing compound­—one capable of rescuing dying cells and restoring cellular communication.1,6,18

Experts are beginning to recognize that with age, many can experience a taurine deficiency that is a real and fundamental threat to health.

The great news is that taurine is a super low-cost supplement, meaning everyone can benefit from its potential to slow and reverse degenerative processes.


Taurine Grows New Brain Cells

For years, scientists believed that brain shrinkage (atrophy) was an unstoppable degenerative process. New research reveals this loss of brain matter is partially caused by reversible processes.19,20 This knowledge opens the door to a new paradigm—one that aims to restore brain structure and function—as opposed to simply treating the symptoms.

BIG SNIP -- SEE REFERENCES HERE:


Gebara E, Udry F, Sultan S, Toni N. Taurine increases hippocampal neurogenesis in aging mice. Stem Cell Res. 2015 May;14(3):369-79.

Pasantes-Morales H, Ramos-Mandujano G, Hernandez-Benitez R. Taurine enhances proliferation and promotes neuronal specification of murine and human neural stem/progenitor cells. Adv Exp Med Biol. 2015;803:457-72.

Liu J, Wang HW, Liu F, Wang XF. Antenatal taurine improves neuronal regeneration in fetal rats with intrauterine growth restriction by inhibiting the Rho-ROCK signal pathway. Metab Brain Dis. 2015 Feb;30(1):67-73.

Hernández-Benítez R, Vangipuram SD, Ramos-Mandujano G, Lyman WD, Pasantes-Morales H. Taurine enhances the growth of neural precursors derived from fetal human brain and promotes neuronal specification. Dev Neurosci. 2013;35(1):40-9.

Gebara E, Udry F, Sultan S, Toni N. Taurine increases hippocampal neurogenesis in aging mice. Stem Cell Res. 2015 May;14(3):369-79.

Toyoda A, Koike H, Nishihata K, Iio W, Goto T. Effects of chronic taurine administration on gene expression, protein translation and phosphorylation in the rat hippocampus. Adv Exp Med Biol. 2015;803:473-80.

Kim HY, Kim HV, Yoon JH, et al. Taurine in drinking water recovers learning and memory in the adult APP/PS1 mouse model of Alzheimer’s disease. Sci Rep. 2014;4 : 7467.

Wenting L, Ping L, Haitao J, Meng Q, Xiaofei R. Therapeutic effect of taurine against aluminum-induced impairment on learning, memory and brain neurotransmitters in rats. Neuro Sci. 2014 Oct;35(10):1579-84.

Zhang L, Yuan Y, Tong Q, et al. Reduced plasma taurine level in Parkinson’s disease: association with motor severity and levodopa treatment. Int J Neurosci. 2015 May 23:1-24.

Engelborghs S, Marescau B, De Deyn PP. Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson’s disease. Neurochem Res. Aug 2003;28(8):1145-50.

Karabacak K, Kaya E, Ulusoy KG, et al. Effects of taurine on contractions of human internal mammary artery: a potassium channel opening action. Eur Rev Med Pharmacol Sci. 2015 Apr;19(8):1498-504.

Sagara M, Murakami S, Mizushima S, et al. Taurine in 24-h urine samples is inversely related to cardiovascular risks of middle aged subjects in 50 populations of the world. Adv Exp Med Biol. 2015;803:623-36.

Ribeiro RA, Santos-Silva JC, Vettorazzi JF, Cotrim BB, Boschero AC, Carneiro EM. Taurine supplementation enhances insulin secretion without altering islet morphology in non-obese diabetic mice. Adv Exp Med Biol. 2015;803:353-70.

Santos-Silva JC, Ribeiro RA, Vettorazzi JF, et al. Taurine supplementation ameliorates glucose homeostasis, prevents insulin and glucagon hypersecretion, and controls beta, alpha, and delta-cell masses in genetic obese mice. Amino Acids. 2015 Aug;47(8):1533-48.

Camargo RL, Branco RC, de Rezende LF, et al. The effect of taurine supplementation on glucose homeostasis: the role of insulin-degrading enzyme. Adv Exp Med Biol. 2015;803 : 715-24.

Han X, Ito T, Azuma J, Schaffer SW, Chesney RW. The quest for an animal model of diabetic nephropathy and the role of taurine deficiency. Adv Exp Med Biol. 2015;803:217-26.

Pandya KG, Budhram R, Clark GJ, Lau-Cam CA. Taurine can enhance the protective actions of metformin against diabetes-induced alterations adversely affecting renal function. Adv Exp Med Biol. 2015;803:227-50.

Parildar H, Dogru-Abbasoglu S, Mehmetcik G, Ozdemirler G, Kocak-Toker N, Uysal M. Lipid peroxidation potential and antioxidants in the heart tissue of beta-alanine- or taurine-treated old rats. J Nutr Sci Vitaminol (Tokyo). 2008 Feb;54(1):61-5.

Kim Y, Kim JW. Toxic encephalopathy. Saf Health Work. 2012 Dec;3(4):243-56.

Pomeroy I, Jordan E, Frank J, Matthews P, Esiri M. Diffuse cortical atrophy in a marmoset model of multiple sclerosis. Neurosci Lett. 2008 May 30;437(2):121-4.

El Idrissi A, Boukarrou L, Splavnyk K, Zavyalova E, Meehan EF, L’Amoreaux W. Functional implication of taurine in aging. Adv Exp Med Biol. 2009;643:199-206.

Perry TL, Bratty PJ, Hansen S, Kennedy J, Urquhart N, Dolman CL. Hereditary mental depression and Parkinsonism with taurine deficiency. Arch Neurol. 1975 Feb;32(2):108-13.

Wu G, Matsuwaki T, Tanaka Y, Yamanouchi K, Hu J, Nishihara M. Taurine counteracts the suppressive effect of lipopolysaccharide on neurogenesis in the hippocampus of rats. Adv Exp Med Biol. 2013;775:111-9.

Ferguson CA, Audesirk G. Effects of DDT and permethrin on neurite growth in cultured neurons of chick embryo brain and Lymnaea stagnalis. Toxicol In Vitro. 1990;4(1):23-30.

Chou C, Lin H, Hwang P, Wang S, Hsieh C, Hwang D. Taurine resumed neuronal differentiation in arsenite-treated N2a cells through reducing oxidative stress, endoplasmic reticulum stress, and mitochondrial dysfunction. Amino Acids. 2015 Apr;47( 4 ) 35-44.

Gu Y, Zhao Y, Qian K, Sun M. Taurine attenuates hippocampal and corpus callosum damage, and enhances neurological recovery after closed head injury in rats. Neuroscience. 2015 Apr 16;291:331-40.
Sun M, Zhao Y, Gu Y, Zhang Y. Protective effects of taurine against closed head injury in rats. J Neurotrauma. 2015 Jan 1;32(1):66-74.

Zhang L, Yuan Y, Tong Q, et al. Reduced plasma taurine level in Parkinson’s disease: association with motor severity and levodopa treatment. Int J Neurosci. 2015 May 23:1-24.
Andreoulakis E, Hyphantis T, Kandylis D, Iacovides A. Depression in diabetes mellitus: a comprehensive review. Hippokratia. Jul 2012;16(3):205-14.

Huang C, Chung C, Leu H, et al. Diabetes mellitus and the risk of Alzheimer’s disease: a nationwide population-based study. PloS One. 2014;9(1):e87095.

Chew BH, Sherina MS, Hassan NH. Association of diabetes-related distress, depression, medication adherence, and health-related quality of life with glycated hemoglobin, blood pressure, and lipids in adult patients with type 2 diabetes: a cross-sectional study. Ther Clin Risk Manag. 2015;11:669-81.

Caletti G, Almeida F, Agnes G, Nin M, Barros H, Gomez R. Antidepressant dose of taurine increases mRNA expression of GABAA receptor alpha2 subunit and BDNF in the hippocampus of diabetic rats. Behav Brain Res. 2015 Apr 15;283:11-5.

Wang G, Pratt M, Macera CA, Zheng Z, Heath G. Physical activity, cardiovascular disease, and medical expenditures in U.S. adults. Ann Behav Med. Oct 2004;28(2):88-94.

Schaffer SW, Ramila KC, Jong CJ, et al. Does taurine prolong life span by improving heart function? Adv Exp Med Biol. 2015;803:555-70.

Packer CS. Changes in arterial smooth muscle contractility, contractile proteins, and arterial wall structure in spontaneous hypertension. Proc Soc Exp Biol Med. 1994 Nov;207(2):148-74.

Miyamoto T, Ueno T, Iguro Y, et al. Taurine-mediated cardioprotection is greater when administered upon reperfusion than prior to ischemia. Adv Exp Med Biol. 2009;643:27-36.

Oriyanhan W, Yamazaki K, Miwa S, Takaba K, Ikeda T, Komeda M. Taurine prevents myocardial ischemia/reperfusion-induced oxidative stress and apoptosis in prolonged hypothermic rat heart preservation. Heart Vessels. 2005 Nov;20(6):278-85.

Dolinsky V, Dyck J. Role of AMP-activated protein kinase in healthy and diseased hearts. Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H2557-69.

Suleiman M, Moffatt A, Dihmis W, et al. Effect of ischaemia and reperfusion on the intracellular concentration of taurine and glutamine in the hearts of patients undergoing coronary artery surgery. Biochim Biophys Acta. 1997 Mar 13;1324(2):223-31.

Lambert J, Nicholson C, Amin H, Amin S, Calvert J. Hydrogen sulfide provides cardioprotection against myocardial/ischemia reperfusion injury in the diabetic state through the activation of the RISK pathway. Med Gas Res. 2014;4(1):20.

Povlsen J, Lofgren B, Dalgas C, et al. Protection against myocardial ischemia-reperfusion injury at onset of type 2 diabetes in Zucker diabetic fatty rats is associated with altered glucose oxidation. PloS One. 2013;8(5):e64093.

Kulthinee S, Wyss JM, Roysommuti S. Taurine supplementation prevents the adverse effect of high sugar intake on arterial pressure control after cardiac ischemia/reperfusion in female rats. Adv Exp Med Biol. 2015;803:597-611.

Schaffer S, Jong CJ, Ramila K, Azuma J. Physiological roles of taurine in heart and muscle. J Biomed Sci. 2010;17 Suppl 1:S2.

Averin E. Use of taurine during rehabilitation after cardiac surgery. Adv Exp Med Biol. 2015;803:637-49.
Foppl M, Hoffmann A, Amann F, et al. Sudden cardiac death after aortic valve surgery: incidence and concomitant factors. Clin Cardiol. 1989 Apr;12(4):202-7.

Anthi A, Tzelepis G, Alivizatos P, Michalis A, Palatianos G, Geroulanos S. Unexpected cardiac arrest after cardiac surgery: incidence, predisposing causes, and outcome of open chest cardiopulmonary resuscitation. Chest. 1998 Jan;113(1):15-9.

Marui A, Kimura T, Nishiwaki N, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol. 2014 Aug 15;114(4):555-61.

Yeung-Lai-Wah JA, Qi A, McNeill E, et al. New-onset sustained ventricular tachycardia and fibrillation early after cardiac operations. Ann Thorac Surg. 2004 Jun;77(6):2083-8.

Available at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0024703/. Accessed June 29, 2015.

Azuma J, Sawamura A, Awata N, et al. Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. Clin Cardiol. 1985 May;8(5):276-82.

Beyranvand M, Khalafi M, Roshan V, Choobineh S, Parsa S, Piranfar M. Effect of taurine supplementation on exercise capacity of patients with heart failure. J Cardiol. 2011 May;57(3):333-7.

Azuma J, Sawamura A, Awata N. Usefulness of taurine in chronic congestive heart failure and its prospective application. Jpn Circ J. 1992 Jan;56(1) 5-9.

Azuma J, Sawamura A, Awata N. Usefulness of taurine in chronic congestive heart failure and its prospective application. Jpn Circ J. 1992 Jan;56(1) 5-9.

Kostoglou-Athanassiou I, Athanassiou P. Metabolic syndrome and sleep apnea. Hippokratia. 2008 Apr;12(2):81-6.

Locatelli F, Pozzoni P, Del Vecchio L. Renal manifestations in the metabolic syndrome. J Am Soc Nephrol. 2006 Apr;17(4 Suppl 2):S81-5.

Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care. 2012 Nov;35(11):2402-11.

Cheng H, Huang J, Chiang C, Yen C, Hung K, Wu K. Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly. J Clin Endocrinol Metab. 2012 Apr;97(4):1268-76.

Ohsawa M, Fujioka T, Ogasawara K, et al. High risks of all-cause and cardiovascular deaths in apparently healthy middle-aged people with preserved glomerular filtration rate and albuminuria: A prospective cohort study. Int J Cardiol. 2013 Dec 10;170(2):167-72.

Steinke J, Mauer M. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Pediatr Endocrinol Rev. 2008 Aug; 5 Suppl 4 : 958-63.

Chesney RW, Han X, Patters AB. Taurine and the renal system. J Biomed Sci. 2010;17 Suppl 1:S4.
Budhram R, Pandya K, Lau-Cam C. Evaluation of the actions of metformin and taurine, singly and in combination, on metabolic and oxidative alterations caused by diabetes in rat erythrocytes and plasma. Adv Exp Med Biol. 2015;803:251-70.

Rosa F, Freitas E, Deminice R, Jordao A, Marchini J. Oxidative stress and inflammation in obesity after taurine supplementation: a double-blind, placebo-controlled study. Eur J Nutr. 2014 Apr;53(3):823-30.

Franconi F, Bennardini F, Mattana A, et al. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr. 1995 May;61(5):1115-9.

Sudic D, Razmara M, Forslund M, Ji Q, Hjemdahl P, Li N. High glucose levels enhance platelet activation: involvement of multiple mechanisms. Br J Jaematol. 2006 May;133(3):315-22.

Dean WL. Role of platelet plasma membrane Ca-ATPase in health and disease. World J Biol Chem. Sep 26 2010;1(9):265-70.

Legedz L, Bricca G, Lantelme P, et al. Insulin resistance and plasma triglyceride level are differently related to cardiac hypertrophy and arterial stiffening in hypertensive subjects. Vasc Health Risk Manag. 2006;2(4):485-90.

Woodman RJ, Chew GT, Watts GF. Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy. Drugs. 2005;65(1):31-74.

Shin J, Lee H, Lee D. Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetes. Cardiovasc Diabetol. 2011;10:30.

Moloney M, Casey R, O’Donnell D, Fitzgerald P, Thompson C, Bouchier-Hayes D. Two weeks taurine supplementation reverses endothelial dysfunction in young male type 1 diabetics. Diab Vasc Dis Res. 2010 Oct;7(4):300-10.

Gizzo S, Patrelli TS, Rossanese M, et al. An update on diabetic women obstetrical outcomes linked to preconception and pregnancy glycemic profile: a systematic literature review. ScientificWorldJournal. 2013;2013:254901.

Heller T, Blum M, Spraul M, Wolf G, Muller UA. Diabetic co-morbidities: prevalences in Germany. Dtsch Med Wochenschr. 2014 Apr;139 (15) : 786-91.

Schuller-Levis G, Park E. Taurine: new implications for an old amino acid. FEMS Microbiol Lett. Sep 26 2003;226(2):195-202.

Qiao M, Liu P, Ren X, Feng T, Zhang Z. Potential protection of taurine on antioxidant system and ATPase in brain and blood of rats exposed to aluminum. Biotechnol Lett. 2015 May 13.

Wang Q, Huang H, Huang Z. Taurine inhibited the apoptosis of glial cells induced by hypoxia. Wei Sheng Yan Jiu. 2015 Mar;44(2):284-7.

Ward R, Dexter D, Crichton R. Ageing, neuroinflammation and neurodegeneration. Front Biosci (Schol Ed). 2015;7:189-204.

Xu S, He M, Zhong M, et al. The neuroprotective effects of taurine against nickel by reducing oxidative stress and maintaining mitochondrial function in cortical neurons. Neurosci Lett. 2015 Mar 17;590:52-7.

Wang Q, Zhu GH, Xie DH, Wu WJ, Hu P. Taurine enhances excitability of mouse cochlear neural stem cells by selectively promoting differentiation of glutamatergic neurons over GABAergic neurons. Neurochem Res. 2015 May;40(5) 24-31.

Neuwirth LS, Volpe NP, Ng S, et al. Taurine recovers mice emotional learning and memory disruptions associated with fragile x syndrome in context fear and auditory cued-conditioning. Adv Exp Med Biol. 2015;803:425-38.

Chang H, Lee DH. Analysis of Taurine as Modulator of Neurotransmitter in Caenorhabditis elegans. Adv Exp Med Biol. 2015;803:489-99.

People are developing dementia earlier and dying of it more, a study shows (link to study below excerpt)

By Daniela Deane August 6

People are developing dementia a decade before they were 20 years ago, perhaps because of environmental factors such as pollution and the stepped-up use of insecticides, a wide-ranging international study has found.

The study, which compared 21 Western countries between the years 1989 and 2010, found that the disease is now being regularly diagnosed in people in their late 40s and that death rates are soaring.

The study was published in the Surgical Neurology International journal, and its findings publicized in the London Times newspaper Thursday.

The problem was particularly acute in the United States, where neurological deaths in men aged over 75 have nearly tripled and in women risen more than fivefold, the leader of the study, Colin Pritchard from Bournemouth University, told the London Times.

Scientists quoted in the study said a combination of environmental factors such as pollution from aircraft and cars as well as widespread use of pesticides could be the culprit, the newspaper reported.